AMSTERDAM – Royal Philips has signed an agreement to acquire Respiratory Technologies, Inc. (RespirTech), a provider of an airway clearance vest for patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease and cystic fibrosis. The expansion of Philips’ respiratory care portfolio with RespirTech’s vest therapy solution and robust clinical support program for in-home respiratory care will further strengthen Philips’ solutions to manage care at home, said John Frank, Philips’ business leader, Sleep & Respiratory Care, in a statement. “With this transaction, we will broaden our portfolio with a proven therapy to enable patients with chronic respiratory disorders to manage their condition and receive the care they need in the home,” he said. “By helping these patients help themselves, we aim to enhance the patient’s quality of life and reduce the overall cost of care.” RespirTech was founded in 2004 and is headquartered in St. Paul, Minn. The company employs approximately 210 employees.
You are here: / / Philips acquires RespirTech, plans to expand at-home respiratory care